Introduction
In a groundbreaking move, EVERSANA, a frontrunner in providing commercial solutions to the life sciences industry, has unveiled the EVERSANA ORCHESTRATE™ MLR platform. This innovative tool is set to significantly alter the landscape of Medical, Legal, and Regulatory (MLR) processes, making substantial strides towards automation and compliance.
The Challenges of Traditional MLR Processes
The conventional MLR review process is laborious, requiring teams to meticulously sift through countless marketing materials while aligning them with regulatory claims. This manual approach not only consumes precious time but also heightens the risk of errors, resulting in compliance issues. Consequently, life sciences companies have been seeking a transformative solution to enhance the efficiency and efficacy of their MLR reviews.
Introducing EVERSANA ORCHESTRATE MLR
The newly launched EVERSANA ORCHESTRATE MLR addresses these challenges head-on by automating up to 90% of routine tasks associated with the MLR process. This advanced platform, built in partnership with Amazon Web Services and consulting firm Modus Create, is designed to ensure compliance with regulatory requirements while providing an easy-to-use interface for implementation.
Key Features and Innovations
The EVERSANA ORCHESTRATE MLR platform is harnessed by Amazon Bedrock, which provides users with access to robust foundation models. This integration facilitates the identification, extraction, and management of marketing claims within minutes—a process that traditionally would take much longer. The platform’s features include:
- - Automation of MLR Reviews: The platform allows users to conduct cross-references of marketing documents against claims data with just a few clicks. This not only accelerates the review process but also significantly reduces the time needed for content updates.
- - Real-Time Updates: Users can quickly identify and update claims in real-time, yielding content updates that are 90% faster and leading to an overall reduction in review cycles by approximately 50%.
- - Enhanced Compliance and Quality: EVERSANA ORCHESTRATE MLR aims to deliver high-quality, consistent materials, boasting an impressive 86% reduction in submission errors after implementation.
The Impact on Life Sciences
According to Jim Lang, CEO of EVERSANA, the ORCHESTRATE MLR platform is a